Mahon Suzanne M
Saint Louis University.
Clin J Oncol Nurs. 2018 Feb 1;22(1):33-36. doi: 10.1188/18.CJON.33-36.
Using direct-to-consumer genetic testing (DTCGT), individuals can order a genetic test, collect and submit a saliva sample, and obtain results about their genetic risk for a variety of traits and health conditions without involving a healthcare provider. Potential benefits of DTCGT include personal control over genetic information and health management decisions, whereas potential risks include misinterpretation of results, psychosocial distress, and lack of informed consent. Oncology nurses can provide education, support, and advocacy to enable patients to truly understand the positives and negatives associated with DTCGT. .
通过直接面向消费者的基因检测（DTCGT），个人可以订购基因检测、采集并提交唾液样本，从而在不涉及医疗服务提供者的情况下获得有关其多种性状和健康状况的基因风险结果。DTCGT的潜在益处包括个人对基因信息及健康管理决策的掌控，而潜在风险包括结果误判、心理社会困扰以及缺乏知情同意。肿瘤学护士可以提供教育、支持及宣传，以使患者真正理解与DTCGT相关的利弊。
